tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corinne Jenkins, 56 are a BUY (56.57%), 32 are a HOLD (32.32%), 11 are a SELL (11.11%).
Analyst Corinne Jenkins, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 67.08% that have a potential upside of 28.94% achieved within 209 days.
Corinne Jenkins’s has documented 201 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ROIV, Roivant Sciences Ltd at 15-Dec-2025.
Analyst best performing recommendations are on AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES) at 9/13/2023. The price target of $10 was fulfilled within 1 day with a profit of $1.16 (10.39%) receiving and performance score of 103.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-May-2024
$18
1 years 9 months 21 days ago
(30-May-2024)
1/1 (100%)
$-1.51 (-7.74%)
19
Hold Since 23-May-2022
$10
$-20 (-66.67%)
$7
3 years 8 months 27 days ago
(24-Jun-2022)
0/2 (0%)
$-19.79 (-66.43%)
Hold Since 08-Jul-2020
3 years 8 months 27 days ago
(24-Jun-2022)
9/9 (100%)
$-23.9 (-54.44%)
596
Sell Since 03-Dec-2021
$16
3 years 9 months 15 days ago
(08-Jun-2022)
1/1 (100%)
$-26.31 (-62.18%)
908
Hold Since 10-Dec-2021
3 years 9 months 27 days ago
(24-May-2022)
2/2 (100%)
$23.57 (109.99%)
1556
Which stock is Corinne Jenkins is most bullish on?
Which stock is Corinne Jenkins is most reserved on?
What Year was the first public recommendation made by Corinne Jenkins?
